Please login to the form below
Healthcare terms - G
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Healthcare terms - G
- Global Health Observatory
- Gatekeeper
- General practitioner (GP)
- Generic medicine
- Generic name
- Genome
- Geo-demographics
- Glass ceiling
- Global brand
- Global Health Index
- Global marketing
- Grey market
- Grey marketing (also called parallel importing)
- Greying, leisured, affluent, middle-aged (GLAM)
- Gross Domestic Product (GDP)
- Group dynamics
- Growth stage
- Guarantees and warranties
- Guerrilla marketing
- Guppie
- Gutter
Featured jobs
- Senior Medical Writer– Medical Education – Oxford - London
-
Excellent Remuneration Package
- Scientific Director - Medical Education - Cheshire & London ...
-
Excellent Remuneration Package
- Senior / Principal Medical Writer – Medical Education - UK &...
-
Excellent Salary and Benefits on offer
- Scientific Director - Medical Communications Agency - New York
-
Excellent Remuneration Package
- Graduate / Entry Level Opportunities – Medical Communications – ...
-
Highly Competitive Remuneration Package
- Senior Medical Writer – Leading Medical Communications Agency – ...
-
Highly Competitive Remuneration Package
- Experienced / Senior Medical Writer - MedComms - Cardiff - Wales
-
Excellent Salary and Benefits on offer
-
Account Director, Medical Education
-
Salary TBC
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
-
Senior Medical Writer
-
Salary TBC
Subscribe to our email news alerts
- Key success factor (KSF)
- China updates drug reimbursement list, agrees price cuts
- UPDATED: BMS completes Celgene merger after FTC okay
- Genital herpes vaccine candidate heads for human studies
- Creativity in storytelling: why pharma must invest more in creativity
- Roche’s Soliris rival satralizumab scores in phase 3 study
- AstraZeneca’s Calquence impresses in previously untreated CLL
- Armed with new data, BMS plans filings for Celgene CAR-T liso-cel
- Bluebird bio’s sickle cell gene therapy shows early-study benefit
- Sangamo steps up BioMarin chase with haemophilia gene therapy data
- The 2019 CPhI Pharma Index Report
- Five key trends in precision and personalised healthcare
PMHub
Nobull Communications
Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...
Quick links
Infographics
